Episurf accelerates shift to pure-play property company, winds down medtech operations
Reuters2026/08/22 18:00- Episurf Medical will accelerate its shift into a pure-play Nordic property company, reallocating capital and resources to its real estate platform.
- The board launched an orderly wind-down of the operating medtech business, citing weak feasibility and high time and capital demands for a sale or spin-off.
- Focus will shift to monetizing the patent portfolio and other intangible assets, rather than continuing in-house production and operations.
- FDA feedback in the Episealer MTP 510(k) process called for additional validation data, increasing required investment and timelines for US clearance.
- The medtech wind-down is expected to lower the cost base, supporting earnings from Q2 2027.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Telstra announces annual shareholder meeting notice
Basecat's market cap reached a peak of 43.6 million USD this morning, with a 24-hour increase of 84.74%.
TEL Venture Capital invests in Japan’s Advance Composite
AI success leads to deflation, failure shifts focus to safety! Apollo Chief Economist: Regardless of the scenario, U.S. Treasury yields will decline in 2027.
Torsten Slok believes that successful AI commercialization will lead to a large-scale deflationary effect, resulting in declining interest rates; if the AI bubble bursts, the Nasdaq could plummet by 50%, prompting a surge of safe-haven funds into US Treasuries and causing yields to drop sharply as well. The next six months are a key window; market narratives are expected to shift from "inflation + fiscal deficit" to the success or failure of AI. Current high interest rates may be on the eve of a turning point.
Crypto prices
More
